It is possible that only gene therapy using adenovirus-based vectors can bring some positive effect(s), as was observed in the case of enzyme replacement therapy for Jansky-Bielschowsky disease (NCL2) caused by mutations in the CLN2 gene [90]. This evidence concerns the gene TPP1 and late infantile neuronal ceroid lipofuscinosis.